Les artériopathies iatrogènes médicamenteuses
- 1 November 1995
- journal article
- abstracts
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 16 (11) , 827-832
- https://doi.org/10.1016/0248-8663(96)80797-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Erythromycin-Associated Ergotamine Intoxication: Arteriographic and Electrophysiologic Analysis of a Rare Cause of Severe Ischemia of the Lower Extremities and Associated Ischemic NeuropathyAnnals of Vascular Surgery, 1993
- Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor: A possible new recombinant granulocyte colony-stimulating factor toxicityCancer, 1992
- ß-Adrenergic Blocker Therapy Does Not Worsen Intermittent Claudication in Subjects With Peripheral Arterial DiseaseArchives of internal medicine (1960), 1991
- ß-Adrenergic Blockers and Intermittent ClaudicationArchives of internal medicine (1960), 1991
- Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold.Journal of Clinical Oncology, 1989
- Refractory vasospasm occurring in a trauma patient receiving dihydroergotamine and heparinCritical Care Medicine, 1988
- Raynaud’s phenomenon in infertile women treated with bromocriptineFertility and Sterility, 1987
- Persisting Raynaud's phenomenon following intralesional bleomycin treatment of finger wartsJournal of the American Academy of Dermatology, 1985
- Treatment with captopril for peripheral ischaemia induced by ergotamine.BMJ, 1984
- Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular CancerAnnals of Internal Medicine, 1981